Envoy Medical (COCH) Capital Expenditures Growth (1y) (2023 - 2025)
Envoy Medical (COCH) Capital Expenditures Growth (1y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.90 Bn | 176.61 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.85 Bn | 125.97 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.77 Bn | 99.55 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.50 Bn | 44.83 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.35 Bn | 2.07 Bn | -47.73% |
| 10 | Envoy Medical | 46.94 Mn | 21.69 Mn | -274,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 123.03% |
| Sep 30, 2025 | -94.96% |
| Jun 30, 2025 | -99.77% |
| Mar 31, 2025 | -94.50% |
| Dec 31, 2024 | -2,642.86% |
| Sep 30, 2024 | 1,467.74% |
| Jun 30, 2024 | 3,836.36% |
| Mar 31, 2024 | 84.75% |
| Dec 31, 2023 | -48.78% |